News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
IRP senior investigator, Richard Youle, Ph.D., received the Breakthrough Prize in Life Sciences for his discoveries about the biological roots of Parkinson’s disease. This award is given to someone who makes “transformative advances toward understanding living systems and extending human life.” The
It is the Genotype-Tissue Expression (GTEx) project’s tenth birthday. This NIH-funded initiative catalogs gene expression and regulation in tissues. This project consists of a huge library with thousands of genetic variations from 838 donors. This library helps to enhance basic and translational
NIH has a long history of ground-breaking research developments that have led to life-changing vaccines and your organization could be a part of the next important vaccine. The NIH Intramural Research Program (IRP) has published an interesting and informative timeline of the various IRP’s